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Abstract. 
 
The signaling events downstream of integrins
that regulate cell attachment and motility are only par-
tially understood. Using osteoclasts and transfected 293
cells, we ﬁnd that a molecular complex comprising Src,
Pyk2, and Cbl functions to regulate cell adhesion and
motility. The activation of integrin 
 
a
 
v
 
b
 
3
 
 induces the
[Ca
 
2
 
1
 
]
 
i
 
-dependent phosphorylation of Pyk2 Y402, its
association with Src SH2, Src activation, and the Src
SH3-dependent recruitment and phosphorylation of
c-Cbl. Furthermore, the PTB domain of Cbl is shown to
bind to phosphorylated Tyr-416 in the activation loop of
Src, the autophosphorylation site of Src, inhibiting Src
kinase activity and integrin-mediated adhesion. Finally,
we show that deletion of c Src or c-Cbl leads to a de-
crease in osteoclast migration. Thus, binding of 
 
a
 
v
 
b
 
3
 
 in-
tegrin induces the formation of a Pyk2/Src/Cbl complex
in which Cbl is a key regulator of Src kinase activity and
of cell adhesion and migration. These ﬁndings may ex-
plain the osteopetrotic phenotype in the Src
 
2
 
/
 
2
 
 mice.
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Introduction
 
In many cell types, the attachment of cells to the extracel-
lular matrix (ECM)
 
1
 
 via integrins leads to activation of
several protein tyrosine kinases and the formation of focal
adhesions, multiprotein complexes that anchor actin stress
fibers to the cytoplasmic face of the plasma membrane
(Longhurst and Jennings, 1998). Highly motile cells such
as osteoclasts, macrophages, and trophoblasts differ in
their attachment, forming podosomes, specialized adhe-
sion sites that are structurally and functionally distinct
from focal adhesions (Marchisio et al., 1984, 1987; Tarone
et al., 1985; Nermut et al., 1991). Although many of the
same proteins are present in podosomes and focal adhe-
sions, focal adhesions are relatively stable, whereas podo-
somes are dynamic attachment structures, undergoing
assembly and disassembly within minutes (Stickel and
Wang, 1987; Chen, 1989, 1990). Interestingly, podosomes
are also observed in v
 
-src
 
-transformed cells, where they
contain high concentrations of Src as well as other tyrosine
phosphorylated proteins (Marchisio et al., 1987; Ochoa et
al., 2000). Activation of Src may therefore be associated
with a shift from stable focal adhesions with actin stress fi-
bers to more dynamic podosome assemblies, possibly reg-
ulating cell motility. Indeed, several papers have suggested
a role for Src in cell spreading and migration (Kaplan et
al., 1995; Meng and Lowell, 1998; Felsenfeld et al., 1999).
More recently, Felsenfeld et al. (1999) demonstrated that
Src reduces the strength of links between the vitronectin
receptor (VnR) and the cytoskeleton when the VnR is
bound to extracellular matrix proteins. Modulation of
these links is essential to generate the forces needed for
cell migration, and reinforcement of these links in the ab-
sence of Src results in a decrease in both cell spreading and
migration. Interestingly, the kinase domain of Src was not
necessary for this process, a finding similar to the results of
Schwartzberg et al. (1997) in genetic rescue experiments of
the Src
 
2
 
 osteopetrotic phenotype. Together, these results
suggest that the predominant role of Src in these processes
might be as an adaptor molecule, recruiting other proteins
that are necessary for the modulation of integrin-cytoskel-
etal links, cell attachment, and migration.
c-Src also plays a critical role in bone resorption, and de-
letion of the gene in mice results in defective osteoclasts
and osteopetrosis (Soriano et al., 1991; Horne et al., 1992;
Tanaka et al., 1992; Lowe et al., 1993; Lowell and Soriano,
1996). Normal osteoclasts have been demonstrated to con-
 
Drs. Sanjay and Houghton contributed equally to this work and should be
considered co-first authors.
Address correspondence to Roland Baron, Department of Cell Biology
and Orthopedics, Yale University School of Medicine, P.O. Box 208044,
New Haven, CT 06510. Tel.: 203-785-5986. Fax: 203-785-2744. E-mail:
roland.baron@yale.edu
 
1
 
Abbreviations used in this paper:
 
 ECM, extracellular matrix; IP, immu-
noprecipitate; mRIPA, modified radioimmune precipitation assay; OCL,
osteoclast-like cell; VnR, vitronectin receptor. 
The Journal of Cell Biology, Volume 152, 2001 182
 
tain podosomes (Marchisio et al., 1984, 1987), but the sig-
naling pathway(s) that Src regulates in osteoclasts has not
been identified. We have previously demonstrated that the
phosphorylation of the proto-oncogene c-Cbl and its local-
ization to the cytoskeleton-rich periphery of the osteoclast
is Src dependent (Tanaka et al., 1996). Studies in a variety
of other cell types have demonstrated that Cbl is tyrosine
phosphorylated in response to the activation of a num-
ber of cell-surface receptors coupled to tyrosine kinases.
These include growth factor receptors, cytokine receptors,
and integrins, such as the 
 
a
 
v
 
b
 
3
 
 vitronectin receptor (Mi-
yake et al., 1997), which is the predominant integrin recep-
tor in osteoclasts and essential for bone resorption (Rodan
and Rodan, 1997). Recent results from several laborato-
ries have also revealed that Cbl can negatively regulate the
tyrosine kinases it binds to (Ota and Samelson, 1997;
Lupher et al., 1998; Broome et al., 1999; Waterman et al.,
1999) and participate in their proteosome-dependent deg-
radation by recruiting ubiquitin-conjugating enzymes to
the complex (Joazeiro et al., 1999; Levkowitz et al., 1999;
Yokouchi et al., 1999).
Since integrins and c-Src play crucial roles in cell migra-
tion and are known to be essential for bone resorption
(Soriano et al., 1991; Duong and Rodan, 1999), we investi-
gated whether integrin-dependent attachment and migra-
tion are defective in Src
 
2
 
 osteoclasts, since such defects
might contribute to the lack of resorptive activity in Src
 
2
 
osteoclasts. We show that while wild-type osteoclasts ex-
hibit podosomes, Src
 
2
 
 osteoclasts have attachment struc-
tures that are reminiscent of more stably attached cells.
Furthermore, they exhibit a decrease in lamellipodia mo-
tility and cell migration, which is also true of osteoclasts
from c-Cbl
 
2
 
 mice.
We also show that Pyk2, a calcium-dependent tyrosine
kinase that is the predominant FAK family member in the
adhesion structures of osteoclasts (Levy et al., 1997; Duong
et al., 1998) is autophosphorylated upon cell attachment,
and subsequently forms a complex with activated Src and
Cbl. In this complex, autophosphorylated Pyk2 binds to
Src’s SH2 domain, while Cbl interacts with Src’s SH3 do-
main. In addition, the overexpression of Cbl’s PTB domain
inhibits Src kinase activity and VnR-mediated cell adhe-
sion, apparently as a result of binding to the autophos-
phorylated Src Tyr416. We conclude that the Pyk2- and
Src-dependent recruitment of Cbl to sites of adhesion may
play a role in regulating cell attachment and motility.
 
Materials and Methods
 
Antibodies and Plasmids
 
The generation of plasmids containing myc-tagged Cbl mutants has previ-
ously been described (Bartkiewicz et al., 1999). To obtain stable transfec-
tions of cells already resistant to G418, these constructs were subcloned
into the pcDNA3.1/Zeo(
 
2
 
) vector as Nhe1/Not1 fragments. The Src con-
structs were generous gifts from Dr. P. Schwartzberg (National Institutes
of Health, Bethesda, MD) and Dr. J. Brugge (Harvard University, Cam-
bridge, MA), and the Pyk2 construct was a generous gift from Dr. J.
Schlessinger (New York University Medical Center, New York, NY). The
G306E mutation of v-Cbl and c-Cbl, and the Y402F and K457A mutations
of Pyk2 were performed as previously described (Lev et al., 1995; Dikic et
al., 1996; Lupher et al., 1998; Sieg et al., 1998).
Anti–Pyk2 and –Cbl antibodies were obtained from Transduction Labo-
ratories. Anti–avian Src, anti–phosphotyrosine (clone 4G10), and anti–vin-
culin antibodies were obtained from Upstate Biotechnology. Anti–v-Src
antibody (clone Ab-1) was obtained from Calbiochem. Anti–Myc antibody
(clone 9E10) was obtained from Santa Cruz Biotechnology, Inc. Anti–
Pyk2 phosphotyrosine residue 402 antibody and anti–Src phosphotyrosine
residue 416 were obtained from Biosource International. (Anti–Src pTyr
416 used in preliminary experiments was a kind gift of Dr. A. Laudano
(University of New Hampshire, Durham, NH). Both anti–rabbit and anti–
mouse secondary antibodies were obtained from Fisher Scientific.
 
Preparation of Authentic Osteoclasts and
Osteoclast-like Cells
 
Authentic osteoclasts were obtained from the long bones of 2–4-d-old neo-
natal mice. Bones were dissected free of adherent tissues, placed in
 
a
 
-MEM containing 5% FBS, and minced into small pieces. After vigorous
pipetting to release osteoclasts, the bone particles were allowed to sedi-
ment for 30 s and the remaining cell suspension containing osteoclasts was
seeded onto serum-coated coverslips. To obtain large numbers of osteo-
clastic cells for biochemical analyses, osteoclast-like cells (OCLs) were gen-
erated in the murine coculture system (Tanaka et al., 1996) by culturing
neonatal primary calvarial osteoblasts with spleen and marrow cells in the
presence of 1,25 dihydroxyvitamin D
 
3
 
 [1,25(OH)
 
2
 
D
 
3
 
] and PGE
 
2
 
. Primary
calvarial osteoblasts were isolated from neonatal mouse calvaria after se-
quential digestion with 0.1% collagenase and 0.2% dispase (Calbiochem),
and then cultured in 
 
a
 
-MEM containing 10% FBS. Cells obtained from
spleens and bone marrow cells from Src
 
2
 
 or Src
 
1
 
 mice (2 
 
3 
 
10
 
8
 
 cells) were
cocultured with osteoblastic cells (10
 
6
 
) in 
 
a
 
-MEM containing 10% FBS,
10
 
2
 
8 
 
M 1,25(OH)
 
2
 
D
 
3
 
, and 10
 
2
 
6 
 
M PGE
 
2
 
 (Sigma-Aldrich). After 4–5 d in
culture, OCLs were purified by removing the osteoblast layer by repeated
pipetting of media. Suspensions of serum-starved (1% FCS overnight)
OCLs were obtained by treating the purified OCLs with 10 mM EDTA for
5 min at 37
 
8
 
C. Cells were then flushed off the culture dishes, washed once
in serum-free 
 
a
 
-MEM, and then resuspended in serum-free medium.
 
Confocal Microscopy
 
Cells were fixed in 3.7% (vol/vol) formaldehyde in PBS for 10 min, and
then washed three times in PBS. Coverslips for cytoskeletal labeling were
extracted in ice-cold acetone for 3–5 min and returned to PBS. All other
coverslips were permeabilized in 0.05% saponin for 30 min. Coverslips for
actin labeling were incubated in a 1:40 dilution (in PBS) of rhodamine
phalloidin stock solution (Molecular Probes), for 20 min, washed several
times with PBS, and mounted in FluorSave (Calbiochem). All other cov-
erslips were blocked in 5% normal goat serum (Boehringer) for 30 min
and incubated in appropriate primary antibodies, washed in PBS, incu-
bated with fluorescein-conjugated secondary antibody, and finally washed
in PBS and mounted in FluorSave. Cells were examined using a confocal
imaging system (MRC-600; Bio-Rad Laboratories). Images were recorded
and composites of the various time courses were compiled and total image
enhancements were performed using Adobe Photoshop 4.0.
 
Osteoclast Motility and Migration Measurements
 
Authentic osteoclasts were freshly isolated, as previously described
(Tanaka et al., 1996), from neonatal Src
 
2
 
 and Cbl
 
2
 
 mice and their wild-
type littermates. Osteoclasts in 
 
a
 
-MEM containing 10% FCS were placed
in the incubation chamber of an inverted phase-contrast microscope
linked via a charge-coupled device camera to a computer-assisted image
analyzer (Trakcell; BIOCOM) and allowed to adhere and spread for 4 h
before measurements were taken. Using a motorized stage and Trackcell-
win software, digitized osteoclast images in several fields in parallel were
recorded at set-time intervals. Over 50 freshly isolated osteoclasts were
analyzed for each group in each experiment. Cells were recorded at 15-
min intervals for 4 h. For each image of the sequence, the coordinated cell
center of gravity was determined and the trajectory of each osteoclast was
calculated. From these trajectories, the length of the cell path was calcu-
lated by determining the sum of distances between successive positions of
the moving cell. Spreading was quantified as lamellipodia area divided by
the total osteoclast area measured at 2-min intervals over a 90-min period.
Motility was defined as the membrane area changes, quantified by calcu-
lating the nonoverlapping area between frames of two successive images
recorded at 2-min intervals over a 90-min period. Statistical analysis was
performed using Student’s paired 
 
t
 
 test.
 
Stable and Transient Transfections
 
Cells were transfected for 5 h using LipofectAMINE™ (Life Technolo-
gies) in 
 
a
 
-MEM following the manufacturer’s protocol. Stable 293-VnR
cell lines expressing myc-tagged Cbl constructs were established by trans- 
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ferring transfected cells into culture medium supplemented with 100 
 
m
 
g/
ml G418 (Life Technologies) and 200 
 
m
 
g/ml Zeocin (Invitrogen) 72 h after
transfection. Cells were maintained in this medium until resistant colonies
of cells were formed (
 
z
 
2 wk). Resistant colonies were subsequently
pooled (
 
.
 
20 colonies) and maintained in culture medium supplemented
with 100 
 
m
 
g/ml G418 and 50 
 
m
 
g/ml Zeocin.
Transiently transfected cells were maintained in 
 
a
 
-MEM containing
10% FCS for 72 h after transfection. Cells were then lysed in modified ra-
dioimmune precipitation assay (mRIPA) or subsequently used in adhe-
sion assays.
 
Integrin Cross Linking and Integrin-mediated 
Adhesion-induced Signaling
 
Mouse osteoclasts were serum starved in 
 
a
 
-MEM for 4–6 h before stimu-
lation. OCLs generated in the coculture system were purified from con-
taminating cells as previously described, and then treated with trypsin-
EDTA for 10 min before antibody cross-linking experiments. Cells were
then washed with ice-cold 
 
a
 
-MEM supplemented with 20 mM Hepes, pH
7.3, and then incubated with a 1:50 dilution of anti–murine VnR poly-
clonal antiserum (Gailit et al., 1997) for 30 min at 4
 
8
 
C. After washing with
ice-cold 
 
a
 
-MEM containing 100 
 
m
 
M sodium orthovanadate, the cells were
incubated in the presence of a 1:100 dilution of anti–rabbit secondary anti-
body prepared in the presence of 20 mM Hepes and 100 
 
m
 
M sodium
orthovanadate at 37
 
8
 
C for the times indicated. Cells were then rinsed in
PBS and lysed in a buffer containing 50 mM Hepes, pH 7.2, 150 mM NaCl,
1% Triton X-100, 10% glycerol, 1 mM EGTA, 1.5 mM MgCl
 
2
 
, 1 mM so-
dium orthovanadate, 1 
 
m
 
g/ml pepstatin, 10 
 
m
 
g/ml leupeptin and aprotinin,
1 mM PMSF, and 50 mM sodium fluoride.
For experiments involving adhesion of OCLs and 293-VnR cells to
ECM proteins, tissue culture–treated plastic or glass coverslips were
coated with 10 
 
m
 
g/ml vitronectin, 10 
 
m
 
g/ml laminin, or 100% FCS over-
night at 37
 
8
 
C. Plates or coverslips were washed three times in PBS before
plating the cells. 293-VnR cells were starved in serum-free medium over-
night before being harvested using trypsin-EDTA. To study the role of
calcium in adhesion-induced signaling, the detached cells were treated
with 100 
 
m
 
M EGTA (to chelate extracellular calcium) for 5 min, or 50 
 
m
 
M
BAPTA (to chelate intracellular calcium) for 30 min, or both. Cells were
then replated, allowed to adhere for the indicated period of time, and
lysed in mRIPA buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.1%
Nonidet P-40, 1% sodium deoxycholate, 10 
 
m
 
g/ml leupeptin, 10 
 
m
 
g/ml
aprotinin, 1 mM sodium orthovanadate, 10 mM NaF, 1 
 
m
 
g/ml pepstatin,
and 1 mM PMSF). Lysates were centrifuged for 30 min at 4
 
8
 
C at 16,000 
 
g
 
,
and the supernatants were used for immunoprecipitation and Western
blot analysis.
 
Coimmunoprecipitation and Western Blotting
 
Lysates were centrifuged for 30 min at 4
 
8
 
C at 16,000 
 
g
 
. Supernatants were
used for immunoprecipitation assays. Typically, 5 
 
m
 
g of antibody was
added to 500 
 
m
 
g of protein lysate and incubated at 4
 
8
 
C for 1 h. 40 
 
m
 
l of
protein-G agarose slurry was added and the incubation continued for an-
other 1 h. The immune complexes on the beads were washed three times
in mRIPA buffer and once in PBS. Beads were boiled in 2
 
3
 
 SDS-PAGE
buffer and samples were electrophoresed on 8% SDS-PAGE gels. Pro-
teins were then transferred to nitrocellulose membranes (BA85; pore size,
0.45 
 
m
 
m) (Schleicher & Schuell). To verify the quality of transfer, proteins
were visualized on the filters by staining with 0.2% Ponceau S in 3%
trichloroacetic acid. To block nonspecific binding, the filters were incu-
bated for 2 h at room temperature in 5% milk, TBST buffer (50 mM Tris-
HCl, pH 7.5, 150 mM NaCl, 0.1% Tween 20). Antigens were visualized by
immunoblotting with the appropriate primary antibody (1:1,000 dilution),
and then a horseradish peroxidase–conjugated anti–mouse IgG or anti–
rabbit IgG antibody. All blots were developed using enhanced chemilumi-
nescence reagents from Amersham Pharmacia Biotech.
 
Adhesion Assay
 
24-well plates were coated overnight at 37
 
8
 
C with 10 
 
m
 
g/ml vitronectin.
Before the adhesion assay, wells were washed three times with PBS. 293-
VnR cells stably expressing the Cbl constructs or control vector were har-
vested by scraping followed by repeated pipetting in serum-free medium
to obtain a single-cell suspension. Cells were then washed and resus-
pended in serum-free medium at 10
 
6
 
 cells/ml. 1 ml of suspension was then
added to each well and incubated at 37
 
8
 
C for 30 min, after which nonad-
herent cells were gently washed off with PBS. The remaining adherent
cells were quantified by staining with MTT (3-[4,5-dimethyiazol-2-yl]-2,5-
diphenyltetrazolium bromide).
 
Kinase Assay
 
c-Src was immunoprecipitated from cells as described above and the Src
kinase activity assayed using a kit from Upstate Biotechnology, as de-
scribed in the manufacturer’s protocol. To ensure equal immunoprecipita-
tion of Src, aliquots of beads were also subjected to Western blot analysis.
 
Results
 
Deletion of Src Leads to Alterations in Adhesion 
Structures, Lamellipodia Motility and Cell Migration
in Osteoclasts
 
Punctate actin- and vinculin-containing podosomes are
typically organized in a ring-like structure at the periphery
of osteoclasts attached to coverslips. To investigate the
role of Src in podosome formation and localization, Src
 
1
 
and Src
 
2
 
 OCLs were plated on vitronectin-coated cover-
slips and allowed to spread for relatively brief periods;
then the distribution of vinculin and actin was analyzed by
confocal microscopy (Fig. 1 A). After 1 h, punctate actin
and vinculin colocalization was apparent in the central re-
gions of both Src
 
1
 
 and Src
 
2
 
 OCLs, with more podosomes
in Src
 
2
 
 cells. In Src
 
1
 
 OCLs, actin and vinculin were also
colocalized in forming lamellipodia, which were not appar-
ent in Src
 
2
 
 OCLs. After 2 h, Src
 
1
 
 OCLs exhibited an in-
crease in the number and length of lamellipodia. In con-
trast, dense concentrations of punctate actin and vinculin
were seen in the interior of the Src
 
2
 
 OCLs at 2 h, with no
apparent formation of lamellipodia.
At a much longer time after plating (16–24 h), Src
 
1
 
 os-
teoclasts showed a characteristic and consistent peripheral
ring-like organization of podosomes (Fig. 1 B), distinctly
different in appearance from the characteristic focal adhe-
sion-like structures seen in the surrounding contaminating
fibroblastic cells. In contrast, all Src
 
2
 
 osteoclasts lacked
this dense ring-like pattern, and these proteins were rela-
tively depleted at the cell periphery. Instead of the punc-
tate podosomal localization seen in freshly purified Src
 
1
 
osteoclasts, actin and vinculin were organized in focal ad-
hesion-like structures, particularly visible with vinculin
staining. Furthermore, actin stress fibers running through
the cytoplasm and anchoring to the plasma membrane at
the site of the focal adhesion-like structures were fre-
quently observed in Src
 
2
 
 cells. These observations sug-
gested that, in the absence of Src, the dynamic and rapid
assembly and disassembly of podosomes was compro-
mised, a change that could possibly translate into a reduc-
tion in cell motility.
We therefore analyzed the motility (movement of the
peripheral cell membrane lamellipodia) and migration
(distance moved) of Src
 
1
 
 and Src
 
2
 
 osteoclasts plated on
serum-coated coverslips. Quantification revealed a 40%
decrease (
 
P
 
 
 
, 
 
0.01) in spreading after 4 h of plating and a
25% decrease in motility (
 
P
 
 
 
, 
 
0.01) compared with Src
 
1
 
osteoclasts (data not shown). When cells were tracked for
a 4-h time period to measure cell migration, a dramatic
60% decrease in the migration of Src
 
2
 
 osteoclasts was evi-
dent (Fig. 1 C, 
 
P
 
 
 
, 
 
0.001). The ratio of cells whose total
migration path was 
 
.
 
80 
 
m
 
m was 
 
z
 
80% for Src
 
1
 
 as com-
pared with only 20% for Src
 
2
 
 cells. In addition, no ex-
tended migration of 
 
.
 
160 
 
m
 
m was observed in Src
 
2 os-
teoclasts, compared with 45% of Src1 cells migrating
distances  .160 mm over the 4-h period (data not shown).
These results indicate that the absence of Src in osteoclastsThe Journal of Cell Biology, Volume 152, 2001 184
disrupts the dynamic regulation of podosomes, and that
this change is associated with a decrease in lamellipodia
motility and cell migration.
c-Cbl2 Osteoclasts also Show Decreased Motility
We have previously shown that Src was also necessary for
the tyrosine phosphorylation of Cbl and its normal local-
ization to podosomes in osteoclasts (Tanaka et al., 1996),
suggesting that Cbl is downstream of Src in osteoclasts
and involved in bone resorption. If so, then Cbl might also
be involved in osteoclast motility. We therefore deter-
mined whether osteoclasts from Cbl2 mice, like those
from Src2 mice, exhibited changes in their ability to mi-
grate. Deletion of c-Cbl significantly reduced the migra-
tion of osteoclasts (Fig. 1 D): in four separate experiments
using a minimum of 70 osteoclasts per experiment, the dis-
tances traveled by Cbl2 osteoclasts was 27% less than
those of Cbl1 cells (P , 0.05). This effect is significantly
smaller than that induced by Src deletion and is appar-
ently not sufficient to give a detectable skeletal phenotype
(Murphy et al., 1998; and data not shown). The lack of
phenotype is probably a consequence of redundancies
with Cbl-b, the expression of which we found to be highly
upregulated in c-Cbl–deficient osteoclasts (data not shown).
Nevertheless, these results indicate that the Cbl family of
proteins is indeed, like Src, involved in the process of os-
teoclast migration.
Signaling through Integrin Receptors and c-Src
in Osteoclasts
The altered adhesion structures and decreased cell motil-
ity are likely to reflect changes in signaling downstream of
integrins. To elucidate how Src might regulate osteoclast
adhesion and motility, we first determined whether Src
was activated by integrins in OCLs. For this purpose, we
used an antibody that specifically recognizes phosphory-
lated tyrosine 416, the autophosphorylation site of murine
c-Src (Thomas and Brugge, 1997). avb3 integrins, the pre-
dominant integrin expressed in osteoclasts, were cross
linked with antibodies against the murine VnR (Gailit et
al., 1997), and the cells were lysed and analyzed. Phosphor-
ylation of tyrosine 416 was detected within 3 min of inte-
grin clustering in Src1 OCLs, reached a maximum at 10
min, and then returned to control levels by 20 min (Fig. 2
A), demonstrating that c-Src is first activated and later de-
activated upon stimulation of the avb3 integrin in OCLs.
Members of the FAK family are also activated by inte-
grins, and Pyk2, a calcium-dependent FAK-related ty-
rosine kinase, is highly expressed in osteoclasts (Duong et
al., 1998). To determine whether Pyk2 is tyrosine phos-
phorylated downstream of integrins in OCLs and whether
this event occurs in a Src-dependent manner, we immuno-
precipitated Pyk2 from lysates of Src1 and Src2 OCLs that
had been replated on vitronectin. After attachment of the
cells, Pyk2 phosphorylation was increased in both Src1
Figure 1. Src deletion leads to
alterations in adhesion struc-
tures and cell migration. (A) Im-
munofluorescence showing actin
(red) and vinculin (green) colo-
calization (yellow) in Src1 and
Src2 OCLs replated on vitronec-
tin for 1 and 2 h. Micrographs
are composites of both channels
together. Note the formation of
vinculin-rich lamellipodia (blue
arrows, Src1 1 and 2 h), which is
not seen in Src2 OCLs, and the
increased redistribution of actin
from the central regions of the
cell (white arrows) to the pe-
ripheral regions of the cell (red
arrow, Src1 2 h) in Src1 OCLs.
These features were not ob-
served in Src2 OCLs where ac-
tin and vinculin colocalization
was observed to significantly in-
crease between 1 and 2 h. (B)
Immunofluorescence showing
actin (red) and vinculin (green)
localization in Src1 and Src2 au-
thentic osteoclasts cultured on
glass coverslips. Note the dis-
tinct ring-like assembly of podo-
somes that stain for both actin
and vinculin in Src1 osteoclasts
(white arrows), and the focal adhesion-like arrangement of vinculin in surrounding contaminating fibroblast-like cells (red arrows, Src1
vinculin). In Src2 osteoclasts, the localization of actin to the periphery of the osteoclast is not observed (yellow arrow, Src2 actin), and
staining for vinculin demonstrates a more focal-adhesion–like arrangement (red arrow, Src2 vinculin) reminiscent of that seen in the
previously described nonosteoclastic cells. (C and D) The lengths of cell migration paths of Src2 (C) and c-Cbl2 (D) osteoclasts and
their littermate wild-type controls were measured at regular intervals as described in Materials and Methods.Sanjay et al. Role of Cbl/Src/Pyk2 Complex in Cell Motility 185
and Src2 cells (Fig. 2 B). In contrast, the tyrosine phos-
phorylation of Cbl was induced in Src1 cells but not in
Src2 cells by plating on vitronectin, confirming our previ-
ous observations (Tanaka et al., 1996). Neither Pyk2 nor
Cbl were phosphorylated in response to adhesion to lami-
nin, a ligand for the a2b1 integrin (Fig. 2 B). This is in
agreement with Duong et al. (1998), who showed that
Pyk2 does not get phosphorylated after cross linking of b1
or b2 integrins. Thus, both Pyk2 and Cbl are phosphory-
lated downstream of avb3 in OCLs, but only Cbl phos-
phorylation requires Src. This defect in Cbl phosphoryla-
tion was not a consequence of decreased spreading of the
Src-deficient cells, since no differences in the spreading of
Src1 and Src2 cells could be detected (data not shown) at
the time points used in these studies (up to 2 h).
Engagement of integrins also leads to increased intracel-
lular Ca21 levels (Sjaastad and Nelson, 1997), a signal that
could activate Pyk2 (Lev et al., 1995). Treatment of iso-
lated osteoclasts with RGD-containing peptides produces
transient increases in intracellular Ca21 levels, which we
found to be independent of the presence of Src (data not
shown). Chelation of intracellular Ca21 by BAPTA signifi-
cantly decreased Pyk2 tyrosine phosphorylation in both
Src1 and Src2 OCLs (data not shown). In contrast, re-
moval of extracellular Ca21 by EGTA had no effect. Using
antibodies to specifically detect Pyk2 phosphotyrosine
402, we determined that phosphorylation of this tyrosine
was induced by adhesion and was also Ca21, but not Src,
dependent (Fig. 2 C). Thus, upon adhesion to ECM, the
initial tyrosine phosphorylation at the autophosphoryla-
tion site Y402, reflecting the activation of Pyk2, results
from changes in intracellular calcium levels and is not me-
diated by or dependent on Src. Since autophosphorylation
of Pyk2 at Y402 creates a consensus binding site for the
SH2 domain of Src (Dikic et al., 1996), we investigated
whether Src, Pyk2, and possibly Cbl, which is known to in-
teract with Src (Tanaka et al., 1996), were present in the
same molecular complexes.
Interactions between Pyk2, Cbl and Src in Osteoclasts
Although Pyk2 and Cbl do not contain any presently iden-
tified domains that would mediate direct interaction, con-
focal microscopic analysis demonstrated that the two
proteins colocalized in the podosome-rich periphery of
osteoclasts as well as in the perinuclear Golgi regions (Fig.
3 A). Since both Pyk2 and Cbl can bind to Src via Src’s
SH2 and SH3 domains, respectively, we investigated the
possibility that Src might act as an adaptor molecule medi-
ating their association. Cbl coimmunoprecipitated with
Pyk2 in Src1 OCLs, and this association was markedly de-
creased in Src2 cells (Fig. 3 B). The residual association of
Pyk2 and Cbl in the Src2 OCLs is most likely due to the
fact that other members of the Src kinase family are ex-
pressed in OCLs, and partially compensates for the ab-
sence of Src (Lowell et al., 1996). Thus, in osteoclasts,
Pyk2 and Cbl are present in podosomes and associate via a
mechanism that is predominantly Src dependent.
Analysis of the Src/Pyk2/Cbl Complex in a Model 
System: Cbl Phosphorylation Downstream of the 
Vitronectin Receptor in 293 Cells Requires both 
Pyk2 and Src Kinase Activity
To analyze the molecular interactions between these three
molecules in greater detail, we further examined the re-
quirement for Pyk2 and Src in signaling downstream of the
avb3 integrin using 293-VnR cells, HEK293 cells that were
stably transfected with the vitronectin receptor (Chunthara-
pai et al., 1993), as a model system. In contrast to results ob-
tained in osteoclasts or in other cell lines (Manie et al., 1997;
Ojaniemi et al., 1997), we failed to observe Cbl tyrosine
phosphorylation when 293-VnR cells were replated on vi-
tronectin-coated dishes for up to 30 min, a time point at
which we could demonstrate the vitronectin-induced phos-
phorylation of FAK, Cas, and paxillin (Fig. 4 A). Similar re-
sults were obtained after more prolonged incubations (data
not shown). Cbl was tyrosine phosphorylated after treat-
Figure 2. Integrin ligation activates Src and increases the ty-
rosine phosphorylation of a number of proteins, including c-Cbl,
but not Pyk2, in a Src-dependent manner. (A) Src was immuno-
precipitated from Src1 OCLs treated with VnR cross-linking an-
tibodies and Western blotted with Src pTyr-416 antibody (top)
that detects the activated form of Src. (Bottom) The same mem-
brane stripped and reprobed with anti-Src Ab. (B) Pyk2 and Cbl
immunoprecipitates from lysates of OCLs plated on laminin
(Lam) or vitronectin (Vn) for 30 min were Western blotted with
anti–p-Tyr antibody (top). Blots were stripped and reprobed with
antibodies against Cbl or Pyk2 (bottom). (C) OCLs were pre-
treated with calcium chelators EGTA (100 mM) and/or BAPTA
(50 mM), as described in Materials and Methods, and allowed to
attach to vitronectin-coated plastic for 30 min. Total cell from ly-
sates were Western blotted for Pyk2pY402 (top), then stripped
and reprobed with anti–Pyk2 antibody (bottom).The Journal of Cell Biology, Volume 152, 2001 186
ment with EGF (data not shown), demonstrating that inte-
grin-independent tyrosine phosphorylation of Cbl can occur
in these cells. Interestingly, both FAK and Cbl are endoge-
nously highly expressed in these cells, but coimmunoprecip-
itation experiments failed to demonstrate the association of
Cbl and FAK in replated cells (Fig. 4 B). Thus, despite
VnR-induced tyrosine phosphorylation events occurring in
the presence of Cbl, Cbl tyrosine phosphorylation was not
induced by integrin activation in 293-VnR cells.
These data suggested that specific protein(s) that are re-
quired for Cbl phosphorylation after adhesion and are
present in some other cell types, including osteoclasts,
were not expressed at sufficient levels in 293-VnR cells.
One of the characteristics of osteoclasts, which exhibit ad-
hesion-induced tyrosine phosphorylation of Cbl, is a high
level of expression of Pyk2 rather than FAK (Levy et al.,
1997; Duong et al., 1998). Examination of Pyk2 expression
in 293-VnR cells showed that Pyk2 was expressed at ex-
tremely low levels in these cells (Fig. 4 C), suggesting that
the absence of Pyk2 could be responsible for the failure of
Cbl to be phosphorylated downstream of integrin engage-
ment. We therefore determined the effect of transiently
overexpressed Pyk2 on adhesion-induced Cbl phosphory-
lation, and found a time-dependent phosphorylation of
Cbl in replated Pyk2-transfected 293-VnR cells (Fig. 4 D).
Thus, the adhesion-induced tyrosine phosphorylation of
Cbl downstream of the vitronectin receptor requires Pyk2.
To confirm that the adhesion-induced phosphorylation of
Cbl was still dependent on Src in the 293-VnR cells that over-
expressed Pyk2, we cotransfected 293-VnR cells with Pyk2
and one of a number of Src mutants/truncations that lacked
kinase activity (Fig. 4 E). These dominant-negative Src mu-
tants abolished Pyk2-dependent adhesion-induced Cbl phos-
phorylation, indicating that both Pyk2 and Src are required
for adhesion-induced Cbl phosphorylation, and suggesting
that Cbl phosphorylation is actually catalyzed by Src.
In 293 Cells, Pyk2 Is Autophosphorylated in an 
Adhesion- and Intracellular
Calcium-dependent Manner
We then proceeded to characterize the specific molecu-
lar mechanism by which Pyk2 and Src mediated the adhe-
sion-induced tyrosine phosphorylation of Cbl, confirming
whenever possible that the model 293-VnR system was re-
sponding in a manner consistent with our findings in
OCLs. To determine whether integrin-induced calcium
signaling was activating Pyk2 in the 293-VnR cells as it
does in OCLs, we examined the effects of BAPTA and
EGTA on attachment-induced Pyk2 phosphorylation. As
in OCLs (Fig. 2 C), chelation of intracellular Ca21 by
BAPTA significantly decreased Pyk2 tyrosine phosphory-
lation in replated cells, while removal of extracellular Ca21
by EGTA had no affect (Fig. 5 A). Furthermore, and
again as in OCLs, the attachment-induced phosphoryla-
tion of Pyk2 was not dependent on Src kinase activity
since it was not inhibited by the overexpression of domi-
nant-negative kinase-deficient or -deleted Src (Fig. 5 B).
Thus, engagement of the avb3 integrin in the 293-VnR
cells appears to induce Ca21-dependent Pyk2 activation
and autophosphorylation, as in untransfected OCLs.
To confirm that Pyk2 autophosphorylation was occur-
ring, we examined the phosphorylation status of Y402.
Phosphorylated Pyk2-Y402 was strongly detected in ly-
sates from cells transfected with wild-type Pyk2, while only
a very low level was present in lysates from cells trans-
Figure 3. Cbl associates with
Pyk2 in a Src-dependent man-
ner, and becomes tyrosine phos-
phorylated by Src in a reaction
that also requires the presence
of Pyk2. Immunocytochemistry
showing Pyk2 and Cbl colocal-
ization in Src1 authentic osteo-
clasts. Micrographs represent in-
dividual channels (red, Pyk2;
green, Cbl) and a merging of the
two channels. Pyk2 was immu-
noprecipitated from Src1 and
Src2 OCLs. Immune complexes
were Western blotted for Cbl
(top left), and then the mem-
branes were stripped and re-
probed with Pyk2 antibodies
(bottom left) Total cell lysates
(TCL) were also electrophore-
sed along with the immunopre-
cipitates. Reciprocal immuno-
precipitation and blotting was
performed using Cbl antibodies
for immunoprecipitation and
Pyk2 antibodies for blotting (top
right). The membrane was
stripped and reprobed with Cbl
antibodies (bottom right).Sanjay et al. Role of Cbl/Src/Pyk2 Complex in Cell Motility 187
fected with the kinase-dead Pyk2K457A (PKM) mutant
(Fig. 5 C), confirming that Y402 is largely phosphorylated
by Pyk2 itself. Like the increase in total Pyk2 phosphoryla-
tion detected by the pan-phosphotyrosine antibody, the
autophosphorylation of Y402 requires increased intracel-
lular Ca21 (Fig. 5 D). Thus, the increase in intracellular cal-
cium that follows VnR binding during cell adhesion, both
in untransfected OCLs and in Pyk2-transfected 293-VnR
cells, leads to the activation of Pyk2 tyrosine kinase and its
autophosphorylation on tyrosine 402.
Autophosphorylated Pyk2 Forms a Complex with Src 
and Cbl
Consistent with the prediction that the phosphorylation of
tyrosine-402 in Pyk2 creates a consensus sequence for Src
SH2 domain binding (Dikic et al., 1996), Src was coimmu-
noprecipitated with Pyk2 from lysates of attached cells,
but not from lysates of cells kept in suspension (Fig. 5 E).
Furthermore, and as predicted by our earlier results, the
association of Src and Pyk2 was markedly diminished
in cells cultured in the presence of BAPTA (Fig. 5 F)
and in cells transfected with kinase-dead Pyk2 (PKM) or
Pyk2 in which the autophosphorylation site was mutated
(Pyk2Y402F or PYF) (E). Thus, VnR engagement induces
the activation and autophosphorylation of Pyk2, resulting
in the recruitment of Src to the adhesion site through an
interaction of Src-SH2 and Pyk2 Tyr-402.
The binding of the autophosphorylated Pyk2Y402 to the
Src SH2 domain will displace the inhibitory phosphoty-
rosine 527 of Src, which would be predicted to activate Src.
To confirm that this is indeed the case in our model sys-
tem, 293-VnR cells were transfected with wild-type Pyk2
or the kinase-dead mutant, PKM, and the adhesion-
induced Src activation was assayed. As expected, replating
Figure 4. Cbl phosphorylation
downstream of the vitronectin
receptor requires Pyk2. (A) Se-
rum-starved 293-VnR cells were
replated on plastic coated with
either polylysine (PLL) or vi-
tronectin (VTN) for 30 min, and
then lysed. FAK, Cas, paxillin,
or Cbl were immunoprecipitated
and analyzed by Western blot-
ting for phosphotyrosine (top).
The membranes were stripped
and reprobed with antibodies
against the immunoprecipitated
antigen (bottom). (B) Cbl and
FAK were immunoprecipitated
from lysates of 293 VnR cells
that had been replated on vi-
tronectin-coated plastic (ATT)
or kept in suspension (SUS),
and the immune complexes ana-
lyzed by Western blotting for
the presence of Cbl (top). (Bot-
tom) Equal amounts of FAK in
the FAK immunoprecipitates.
(C) The total cell lysates (TCL)
of 293 VnR cells transfected
with vector control (2) or Pyk2
(1) were probed with Pyk2 anti-
bodies to show expression of ex-
ogenous Pyk2 (1) (right). (D)
293-VnR cells transfected with 5
mg of either control vector (2)
or Pyk2 (1) were harvested and
either kept in suspension or
plated on vitronectin-coated
plastic for the indicated times.
The cells were then lysed and
Cbl was immunoprecipitated
and Western blotted for P-Tyr
(top). Membranes were then
stripped and reprobed for Cbl
(middle). Total cell lysates
(TCL) were blotted for Pyk2 to
ensure expression (bottom). (E)
293-VnR cells were transfected with a combination of 5 mg Pyk2 expression vector and 5 mg of cDNAs encoding various kinase-inactive
Src mutants. The cells were harvested, and then either kept in suspension (SUS) or plated on plastic coated with polylysine (PLL) or se-
rum (FBS) for 30 min. The cells were then lysed and Cbl was immunoprecipitated and Western blotted for p-Tyr (top). The membrane
was reprobed for Cbl. Total cell lysate (TCL) blots were probed with antibodies to Pyk2 or avian Src to ensure expression.The Journal of Cell Biology, Volume 152, 2001 188
the cells caused an increase in the level of autophosphory-
lated Src (approximately twofold) in cells transfected with
wild-type Pyk2, but not in cells transfected with PKM or
with the empty vector (Fig. 5, G and H), indicating that
Pyk2 kinase activity is required for the efficient adhesion-
induced activation of Src.
We then determined whether Cbl, whose phosphoryla-
tion is dependent upon both the presence of Pyk2 and the
kinase activity of Src (Fig. 4, D and E), was present in the
same molecular complex as Src and Pyk2. As shown in Fig.
6, Pyk2 and Cbl could be coimmunoprecipitated from ly-
sates of replated cells. This association was independent of
Src kinase activity; i.e., independent of Cbl’s phosphoryla-
tion, since the overexpression of dominant-negative Src
mutants that lacked kinase activity failed to block the as-
sociation (Fig. 6 A).
Src Is an Adaptor Molecule Mediating the Interaction 
of Pyk2 and Cbl
Despite the presence of a number of protein binding do-
mains in Pyk2 and Cbl, the two proteins lack known com-
plementary domains that would mediate a direct inter-
action between them. They both bind to different Src
domains, however, and we hypothesized that Src acts as an
adaptor molecule mediating their association, with auto-
phosphorylated Pyk2 Y402 binding to the Src SH2 domain
and the Cbl proline-rich region binding to the Src SH3 do-
main. The adaptor role of Src was further supported by the
fact that Src mutants in which the kinase domain or the
whole COOH-terminal half were deleted could still associ-
ate with both Pyk2 and Cbl (Figs. 4 E and 6 A). The role of
autophosphorylated Pyk2 Y402 was confirmed by the fail-
ure of either the kinase-dead PKM or the Pyk2Y402F mu-
tant to associate with Src (Fig. 5 E) or with Cbl (Fig. 6, B
and C) in replated cells.
Finally, to verify the involvement of the Src SH2 and
SH3 domains, we transfected 293-VnR cells with various
mutants of Src, immunoprecipitated Src or Cbl, and ana-
lyzed the immunoprecipitates for the presence of Cbl and
Pyk2, respectively. When Src was immunoprecipitated,
Cbl was observed in all immune complexes except those
from cells overexpressing Src DSH3 (Fig. 6 D), confirming
that the SH3 domain of Src was necessary for the efficient
association of these proteins. Cbl coimmunoprecipitated
Figure 5. Pyk2 is autophosphor-
ylated at Y402 after adhesion
and associates with Src via the
phosphorylated Y402. (A) 293-
VnR cells transiently trans-
fected with 5 mg of Pyk2 were
treated with calcium chelators
BAPTA and/or EGTA, and
then replated on serum-coated
plastic and allowed to attach to
vitronectin-coated plastic for 30
min. Pyk2 IPs from lysates were
Western blotted for P-Tyr (top),
and then reprobed with anti–
Pyk2 (bottom). (B) 293-VnR
cells were transiently trans-
fected with Pyk2 (5 mg) or
cotransfected with Pyk2 (5 mg)
and Src kinase-inactive mutants
(10 mg). Pyk2 IPs from lysates
were probed with P-Tyr anti-
bodies (top). Membrane was
stripped and reprobed with
Pyk2 (bottom). (C) Pyk2 and
Pyk2 mutants Y402F (PYF) and
K457A (PKM) were transiently
expressed in 293-VnR cells and
total cell lysates (TCL) were
blotted with an antibody specific
for Pyk2 phosphorylated residue
402 (top). (Bottom) Trans-
fected proteins. (D) Cells were
processed as in A and Pyk2 IPs
were blotted with an antibody
specific for Pyk2 phosphorylated residue 402 (top). (Bottom) Pyk2 blot demonstrating equal loading. (E) 293-VnR cells were tran-
siently transfected with wild-type Pyk2, kinase-dead Pyk2 (PKM) or Pyk2Y402F (PKF). The transfected cells were harvested, and then
kept in suspension (SUS) or replated on serum-coated plastic (ATT) as in Fig. 4 E. Association of Src with mutant Pyk2 proteins was
analyzed by Western blotting Src immunoprecipitates with Pyk2 antibodies (top). (Bottom) The membrane reprobed with Src antibod-
ies. (F) Src IPs from cells treated with either EGTA or BAPTA were blotted with Pyk2 antibodies (top). (Bottom) The membrane rep-
robed with anti–Src. (G) 293-VnR cells transfected with 5 mg of Pyk2 or dominant-negative kinase-dead Pyk2 (PKM) were either kept
in suspension or replated on vitronectin coated dishes for 30 min. Lysates were immunoprecipitated with anti–Src antibodies and
probed with Src pTyr-416 antibody (top), which detects the activated form of Src. The membrane was stripped and reprobed with anti–
Src (bottom). (H) Src kinase activity was quantified as an increase in pY416 Src using Scion Image1.62 C program.Sanjay et al. Role of Cbl/Src/Pyk2 Complex in Cell Motility 189
with Src independent of its kinase activity; i.e., with a con-
stitutively active form of Src (E378G), which hyperphos-
phorylates Cbl, and a number of kinase dead/deleted Src
mutants (data not shown), which are incapable of phos-
phorylating Cbl. Thus, although the Src kinase domain
and its activity are required for Cbl phosphorylation, nei-
ther is necessary for the association between Cbl and Src.
The absence of either the SH2 or SH3 domains of Src
resulted in a decrease in the amount of Pyk2 that coimmu-
noprecipitated with Cbl (Fig. 6 E), confirming that both
domains of Src are necessary for the Src-mediated associa-
tion of Pyk2 and Cbl, and suggesting that Pyk2 and Cbl
were indeed associating via a single Src molecule. Thus, as
in the OCLs (Fig. 3 B), Pyk2, Src, and Cbl form a trimolec-
ular complex in the 293-VnR cells that is induced by the
engagement and activation of the avb3 integrin. Subse-
quent Ca21-dependent activation and autophosphoryla-
tion of Pyk2 leads to the recruitment and activation of Src
via the Pyk2 pY402-Src SH2 interaction, while the proline-
rich domain of Cbl binds to the Src SH3 domain.
Cbl Regulates Src Kinase Activity within the Complex
Cbl is known to be a negative regulator of several receptor
and nonreceptor tyrosine kinases (Tanaka et al., 1995;
Wang et al., 1996; Barber et al., 1997; Manie et al., 1997).
We therefore hypothesized that while the binding of Cbl
to the SH3 domain of Src might contribute to the full acti-
vation of Src kinase, as do other proline-rich ligands of the
SH3 domains of several Src family members (Xu et al.,
1999), the presence of Cbl in the complex might also lead
to a secondary negative regulation. Thus, the presence of
Cbl in the trimolecular complex could provide a mecha-
nism to insure the transience of attachment-induced Src
kinase activity. To determine whether Cbl in fact inhibited
Src kinase activity, we transiently transfected a number of
Cbl mutants, including the oncogenic 70Z-Cbl (missing
part of the RING finger) and v-Cbl (truncation of the
whole COOH-terminal half), into cells that overexpressed
a constitutively active mutant of Src (Src Y527F). Full-
length Cbl, 70Z-Cbl and v-Cbl inhibited the kinase activity
of immunoprecipitated Src by 35, 28, and 37%, respec-
Figure 6. Src acts as an adaptor
molecule mediating interactions
between Cbl and Pyk2. (A) As-
sociation of Cbl with Pyk2 in
presence of Src kinase mutants
was analyzed by probing the blot
of Cbl immunoprecipitates with
Pyk2 antibodies (top). The blot
was stripped and reprobed with
Cbl antibodies. Total cell lysates
(TCL) were Western blotted
with Pyk2 and avian Src antibod-
ies to check expression of trans-
fected proteins. (B) 293-VnR
cells were transfected with Pyk2,
PKM, or empty vector (pBK).
Cbl was immunoprecipitated
from lysates of replated cells and
analyzed for the presence of
phosphotyrosine (top). (C) 293-
VnR cells were transfected with
Pyk2 mutants. The attachment-
induced association of the mu-
tant Pyk2 proteins with Cbl (top)
was analyzed by blotting Cbl IPs
with anti–Pyk2 antibody. (D)
Cbl IPs from lysates of 293-VnR
cells transfected with 10 mg of
the indicated Src expression vec-
tor were blotted with an an-
tiphosphotyrosine antibody to
demonstrate the effects of these
Src mutants of Cbl phosphoryla-
tion. Src was immunoprecipi-
tated from the same lysates and
the immune complexes were
blotted for the presence of Cbl.
(E) 293-VnR cells were trans-
fected with a combination of 3
mg Pyk2 and 3 mg of the indi-
cated Src expression vector. Cbl
IPs were analyzed for the pres-
ence of Pyk2 (top). (Bottom)
Expression of the Src mutants in
total cell lysates (TCL).The Journal of Cell Biology, Volume 152, 2001 190
tively, (P , 0.01, Fig. 7 A), comparable with the transfec-
tion efficiency (30–50%, as demonstrated using a green
fluorescent protein expression vector) while transfection
with empty vector or expression of the COOH-terminal
half of Cbl had no effect.
Inhibition of Src Kinase by Cbl Is PTB
Domain Dependent
The inhibition of Src kinase activity by v-Cbl suggested
that the NH2 terminus of Cbl can bind to Src. We therefore
sought to determine whether that is indeed true and, if so,
to identify the requirements for such an interaction. As ex-
pected, full-length Cbl, 70Z-Cbl, and Cbl-COOH termi-
nal, all of which contain the proline-rich domain and
therefore bind to SH3, were present in Src immunoprecip-
itates (IPs). v-Cbl was also detected in Src IPs, albeit at
lower levels, confirming that the NH2-terminal half of Cbl
is capable of binding to Src (Fig. 7 B).
Since the PTB domain is the only functional domain
identified in v-Cbl, we considered the possibility that this
domain mediated the binding to Src and, possibly, the in-
hibition of its kinase activity. Interestingly, Src Y416, the
autophosphorylated residue in Src’s activation loop, oc-
curs in the sequence DNEY, which, when phosphorylated
on tyrosine, matches the preferred binding motif D(D/
N)xpY for the Cbl PTB domain (Lupher et al., 1997), sug-
gesting that the Cbl PTB domain might bind to phos-
phorylated Src Y416. We therefore sought to confirm that
the Cbl PTB-Src pY416 interaction mediates the interac-
tion of v-Cbl and Src.
A single point mutation, G306E, abolishes the binding
ability of the PTB domain (Bonita et al., 1997). We there-
fore introduced this mutation into both c-Cbl and v-Cbl,
and then determined the effect of the mutation on the
binding of c-Cbl or v-Cbl to a constitutively active Src
(SrcE378G). The G306E mutation had no effect on the as-
sociation of full-length Cbl with Src (Fig. 8 A), consistent
with our observation that the primary association of Src
with Cbl is mediated by the proline-rich SH3 interaction.
The mutation did, however, prevent the binding of v-Cbl
to Src, confirming the involvement of Cbl’s PTB domain in
the v-Cbl–Src interaction.
To confirm that the phosphotyrosine 416 was indeed the
target of the PTB domain, coimmunoprecipitation experi-
ments were performed with lysates from 293-VnR cells
that stably express myc-tagged v-Cbl and were transiently
transfected with Src E378G or Src Y416F. v-Cbl was
present only in Src E378G immune complexes (Fig. 8 B),
indicating that mutation of tyrosine 416 abolished the in-
teraction between v-Cbl and Src in a manner similar to the
G306E mutation in Cbl.
Finally, since the G306E mutation of Cbl abolished the
binding of v-Cbl to Src, we examined the effect of the mu-
tation on Cbl’s inhibition of Src kinase activity. The muta-
tion completely blocked the ability of overexpressed v-Cbl
to inhibit the Src’s kinase activity (Fig. 8 C), implying that
while the initial and predominant interaction between Src
and Cbl is likely via the Src SH3-Cbl proline-rich domains,
the PTB domain of Cbl can subsequently bind to the auto-
phosphorylation site on Src’s activation loop to inhibit Src
Figure 7. Cbl inhibits Src ki-
nase activity by binding to Src.
(A) NIH3T3 cells that stably ex-
press a constitutively active Src
(SrcY527F) were transfected
with 10 mg of the indicated Myc-
tagged Cbl cDNA and expres-
sion was demonstrated by im-
munoblotting using an anti–Myc
antibody (top). Src was immu-
noprecipitated and the kinase
activity was measured and ex-
pressed as a percentage of the
control kinase activity levels
(pBK-transfected cells). The
amount of immunoprecipitated
Src in the kinase assay was as-
sessed by immunoblotting. (B)
293-VnR cells that stably ex-
press the myc-tagged Cbl con-
structs (top) were transfected
with 10 mg of active Src
(SrcE378G). Src was immuno-
precipitated and the immune
complex was immunoblotted to
detect myc-tagged proteins
(middle) and Src (bottom).Sanjay et al. Role of Cbl/Src/Pyk2 Complex in Cell Motility 191
kinase activity. We also measured the kinase activity of ac-
tivated Src in presence of c-Cbl and c-Cbl G306E proteins.
Although the inhibition of Src kinase activity was not com-
pletely abolished by the mutation, as was the case with
v-Cbl, the activity of Src from cells transfected with
c-CblG306E was 66% greater than that of Src from cells
transfected with Cbl (data not shown), confirming that the
Cbl PTB/Src pY416 interaction contributes to the inhibi-
tion of Src by c-Cbl.
To further confirm that the Cbl PTB domain binds to
the Src pY416, we characterized the effect of wild-type
Cbl and CblG306E on the Src pY416 content, reasoning
that binding to the PTB domain would protect the phos-
photyrosine from phosphatase-catalyzed hydrolysis. Cells
were cotransfected with SrcE378G and either c-Cbl,
c-CblG306E, v-Cbl, or v-CblG306E, and then Src was im-
munoprecipitated and blotted for pY416. Mutation of
both c-Cbl and v-Cbl resulted in less Src pY416 (Fig. 8 D),
providing further support for the presence of an interac-
tion between the Cbl PTB domain and phosphorylated Src
Y416. Together, these data clearly demonstrate that Src
and Cbl interact not only via Src SH3, but also through a
Cbl PTB-Src kinase domain interaction. Most importantly,
this latter interaction inhibits Src kinase activity. Thus, the
recruitment of Cbl to Src serves to downregulate the ki-
nase activity of Src, initially stimulated after integrin acti-
vation by the binding of both Pyk2 and Cbl to Src SH2 and
SH3 domains, respectively.
Cbl also Inhibits Cellular Adhesion of 293 Cells to 
Vitronectin via its PTB Domain
Our results show that Cbl is recruited to a Pyk2- and Src-
containing complex as a consequence of integrin engage-
ment and activation, and that the association of Cbl with
this complex leads to decreased Src kinase activity. Since
Cbl regulates b1 integrin-mediated cell adhesion down-
stream of the CD28 cytoplasmic domain (Zell et al., 1998),
we next sought to determine whether Cbl could regulate
the VnR-mediated adhesion of 293-VnR cells. 293-VnR
cells were stably transfected with various Cbl constructs,
Figure 8. The association of the
Cbl PTB domain with Src phos-
photyrosine residue 416 results
in an inhibition of Src kinase ac-
tivity. (A) 293-VnR cells were
transiently cotransfected with 5
mg Src E378G and 5 mg of nor-
mal or G306E-mutated forms of
Cbl and v-Cbl. After immuno-
precipitating Src, immune com-
plexes were blotted for associ-
ated Cbl protein (top). The
efficiencies of Src immunopre-
cipitation (middle) and Cbl ex-
pression (bottom) were deter-
mined. (B) 293-VnR v-Cbl
cells were transiently trans-
fected with active avian Src
(SrcE378G) or avian Src Y416F.
Avian Src was immunoprecipi-
tated and blotted for the pres-
ence of myc-tagged v-Cbl. v-Cbl
expression (middle) and effi-
ciency of Src immunoprecipita-
tion (bottom) were analyzed.
(C) The kinase activity of immu-
noprecipitated Src from cells
transfected with a combination
of 5 mg SrcE378G and 5 mg of ei-
ther v-Cbl or v-CblG306E was
measured and expressed as a
percentage of the control kinase
activity levels (pBK-transfected
cells). v-Cbl expression (middle) and efficiency of Src immunoprecipitation (bottom) were analyzed. (D) 293-Vnr cells were transiently
cotransfected with 5 mg Src E378G and 5 mg normal or G306E mutated form of Cbl and v-Cbl. Src was immunoprecipitated and im-
mune complex was immunoblotted with SrcY416 (top). The blot was reprobed with Src (bottom). The Journal of Cell Biology, Volume 152, 2001 192
and the adhesion of the different cell lines to vitronectin
was tested. All Cbl constructs that contained the PTB do-
main significantly inhibited the number of cells that ad-
hered to vitronectin (Fig. 9), without affecting the expres-
sion of either subunit of the VnR (data not shown). In
contrast, Cbl-C and empty vector controls had no signifi-
cant effect. Interestingly, no inhibition of adhesion to fi-
bronectin was observed (data not shown), suggesting that
this effect of Cbl was specific for the VnR. Interestingly,
the c-Cbl G306E mutant had the opposite effect (i.e., it led
to a marked and significant increase in cell adhesion)
(144%, P , 0.001) (Fig. 9), suggesting that a Cbl mutant
that binds to the Src SH3 domain but cannot bind Src
pY416 has a dominant-negative effect on the modulation
of cell adhesion by endogenous c-Cbl, possibly by prevent-
ing the negative regulation of Src kinase. Taken together,
these results suggest that Cbl molecules that contain a
functional PTB domain inhibit both the activity of Src ki-
nase and the adhesion of cells to vitronectin, which further
suggests that the strength of VnR-matrix interactions may
be directly or indirectly (i.e., via Src) modulated by Cbl.
Discussion
Cyclic attachment and detachment of individual podo-
somes is required as cells, particularly highly motile cells
such as macrophages and osteoclasts, migrate over a sub-
stratum. Our data suggest that Pyk2, Src, and Cbl may play
a pivotal role in these processes. First, we have demon-
strated that deletion of Src significantly alters the initial
distribution of podosomes in osteoclasts, eventually lead-
ing to the formation of focal adhesion-like structures. This
shift from podosome to focal adhesion correlates with a
decrease in the formation and motility of lamellipodia and
in cell migration, although it is not possible to determine
which comes first. We find that adhesion to vitronectin or
activation of the avb3 receptor induces an increase in intra-
cellular calcium that does not depend on the presence of
Src. Using both osteoclasts and transfected 293-VnR cells
in which this pathway has been reconstructed, we also
show that Pyk2 is autophosphorylated at tyrosine 402 in a
Src-independent, [Ca21]i-dependent manner, creating a
binding site for the SH2 domain and recruiting Src. Cbl is
then recruited to this complex, binding to the SH3 domain
of Src, or, alternatively, it may be constitutively bound to
inactive Src but be phosphorylated only after Src is acti-
vated by binding to Pyk2. In either case, the formation of a
kinase-rich trimolecular complex, which we observed in
both OCLs and 293-VnR cells, results in the Pyk2- and
Src-dependent phosphorylation of Cbl. Therefore, Pyk2,
Src, and Cbl are all involved in the “outside-in” avb3 inte-
grin signaling which, we propose, results in podosome as-
sembly. In addition, we have also demonstrated that, in
transfected 293-VnR cells, the PTB domain of Cbl binds to
Tyr 416 in the activation loop of the Src kinase domain,
and that this interaction downregulates both Src kinase ac-
tivity and integrin-mediated adhesion. Thus, Cbl might
also be crucial in “inside-out” signaling, playing a key role
in podosome detachment and subsequent disassembly. In
agreement with this hypothesis, we also found that dele-
tion of the gene encoding Cbl, like the deletion of the gene
encoding Src, leads to a significant, albeit smaller, de-
crease in osteoclast migration. The series of events de-
scribed above could therefore form the basis for the cyclic
attachment–detachment of single adhesion sites at the
leading edge of lamellipodia in motile cells, and thereby
participate in the assembly–disassembly of individual po-
dosomes, thereby ensuring cell adhesion while still allow-
ing cell motility.
This interpretation is consistent with the existing litera-
ture. It is known that, unlike FAK, Pyk2 can be activated by
an increase in intracellular calcium (Lev et al., 1995), and
we show here that such an event occurs in both osteoclasts
and 293-VnR cells upon avb3 integrin ligation. We also con-
firm here that this results in the autophosphorylation of
tyrosine 402, which generates a binding site for the SH2
domain of Src (Dikic et al., 1996). The binding of phos-
photyrosine motifs to the Src family SH2 domains is known
to cause a conformational change resulting in the partial ac-
tivation of the Src kinase and autophosphorylation of a ty-
rosine in the activation loop (Xu et al., 1999), and we indeed
demonstrate that integrin ligation leads to the phosphoryla-
tion of tyrosine 416 in Src. We also found that Cbl binds to
the SH3 domain of Src. As demonstrated by Xu et al.
(1999), the binding of proteins to both the SH3 and SH2 do-
mains of Src family members induces the complete activa-
tion of their kinase. The binding of Cbl to Src results in the
tyrosine phosphorylation of Cbl, which we demonstrate
here is Src-dependent downstream of the avb3 integrin.
One major finding in this study is that Cbl plays a piv-
otal role in this complex, not only by binding to the Src
SH3 domain and possibly thereby contributing to the acti-
vation of Src, or as an adaptor recruiting more proteins to
the complex, but also as a kinase inhibitor, providing a
mechanism that might ensure that the activity of Src ki-
nase within the complex at the attachment site is transient.
We show here that this function involves the binding of
the Cbl PTB domain to the Src phosphotyrosine 416. In-
terestingly the PTB domain also modulates VnR-medi-
ated attachment, regulating adhesion to vitronectin but
not fibronectin. Furthermore, the G306E mutation of the
Figure 9. Cbl regulates vitronectin receptor–mediated 293-VnR
adhesion. The adhesion of 293-VnR cells stably expressing a
number of Cbl constructs was measured as described in Materials
and Methods and expressed as a percentage of control (untrans-
fected 293-VnR cells). The graph represents pooled data from
two individual experiments.Sanjay et al. Role of Cbl/Src/Pyk2 Complex in Cell Motility 193
PTB creates a form of c-Cbl that acts in a dominant-nega-
tive manner on the c-Cbl-induced downregulation of cell
adhesion, providing further evidence that Cbl may regu-
late cell adhesion and that this occurs, at least in part, via
the interaction of its PTB domain with Src Tyr-416. This
specific inside-out effect of Cbl could be the result of the
inhibition of Src kinase activity, of a direct modulation of
integrin binding, of an indirect modulation via other ty-
rosine kinases or the cytoskeleton, or a combination of ef-
fects. Interestingly, our findings and those of Felsenfeld et
al. (1999) show that both Src and Cbl negatively regulate
the adhesion of VnR to vitronectin, whereas adhesion to
fibronectin is unaffected. This suggests a certain level of
specificity of this molecular complex for the vitronectin re-
ceptor, possibly linked to the recruitment and calcium-
dependent activation of Pyk2 as opposed to FAK. Further
work will be required to address these questions.
Cbl’s inhibition of several other tyrosine kinases, includ-
ing EGFR, PDGFR, and Syk has been reported (Ota and
Samelson, 1997; Lupher et al., 1998; Waterman et al.,
1999). In all cases, Cbl’s PTB domain has been shown to be
responsible for Cbl’s recruitment and binding. However,
our findings illustrate the fact that Cbl can also be re-
cruited to the activated tyrosine kinase Src via the SH3 do-
main and that it is the specific binding of Cbl’s PTB do-
main to the activation loop in Src’s kinase domain that is
responsible for inhibition of the kinase activity. Nearly all
other members of the Src family possess the Cbl PTB bind-
ing consensus motif (DNEY) at their autophosphorylation
site and, therefore, by analogy to Src, could also be inhib-
ited by association with Cbl. Although v-Cbl was able to
associate with Src in a cellular overexpression system, the
association of the COOH-terminal half of Cbl (containing
the proline-rich domain) was observed to be much greater,
so that association of full-length Cbl with Src was unaf-
fected by the G306E mutation. It therefore seems likely
that, under normal conditions (i.e., endogenous levels of
protein expression), the Src SH3 interaction with the Cbl
proline-rich domain occurs first and that the interaction
between the Cbl PTB domain and the autophosphorylated
tyrosine occurs only secondarily, possibly only transiently
and as a consequence of Cbl phosphorylation. This repre-
sents a novel mechanism by which Cbl might modulate Src
tyrosine kinase-dependent signaling events and VnR-
mediated cell adhesion and motility. The smaller decrease
in the motility of Cbl2 cells (relative to Src2 cells) is prob-
ably due to the partial compensation for the absence of
c-Cbl in osteoclasts by Cbl-b, which contains identical
functional domains (Keane et al., 1995), is overexpressed
in c-Cbl2 OCLs, and coimmunoprecipitates with Pyk2 from
OCL lysates (our unpublished observations).
In models using genetically modified cells, the short-
term strength of adhesive contacts has been demonstrated
to regulate migration rates as net traction forces result
from an unequal distribution of adhesive contacts between
the leading and trailing edges (Lauffenburger and Hor-
witz, 1996; Palecek et al., 1998). The adhesive strength of
integrin-mediated substrate contacts, and thus migration
rates, can be modulated by altering either integrin–ligand
affinity, cell-surface integrin expression levels, substrate–
ligand concentrations, or integrin–cytoskeletal coupling
(Palecek et al., 1997). Interestingly, the forces generated
by the cytoskeleton are increased in the absence of Src
(Felsenfeld et al., 1999), and this results in decreased
spreading (Kaplan et al., 1995) and, as shown here, de-
creased motility. Our data suggest that the motility defect
exists before the formation of focal adhesions, since all
motility measurements were made using osteoclasts within
4 h of initial attachment, a time frame in which we do not
yet see the formation of stress fibers and focal adhesions in
Src2 OCLs, but rather observe a defect in the localization
of podosomes. Since we found podosomes to be more nu-
merous in freshly plated OCLs in the absence of Src, we
propose that Src deletion affects podosome disassembly
rather than assembly.
We further suggest that the apparent stronger attach-
ment of Src-deleted cells (Felsenfeld et al., 1999) results
from Cbl failure to be recruited and/or phosphorylated at
the adhesion sites. This view is supported by the fact that
the absence of Src causes a significant reduction in the
amount of Cbl associated with Pyk2 and with podosomes
at the periphery of the cell (Tanaka et al., 1996). As in
Felsenfeld et al. (1999), the recruitment of Cbl is appar-
ently independent of Src’s kinase activity, suggesting that
Src’s role in this process is primarily as an adaptor protein.
A role for Src as an adaptor molecule has been suggested
previously by the rescue of the Src2 osteopetrotic pheno-
type by osteoclast-specific expression of kinase-deficient
Src mutants (Schwartzberg et al., 1997). Thus, tyrosine
phosphorylation of Cbl, which requires an active Src ki-
nase, may not be critical for podosome assembly and/or
disassembly. It should, however, be noted that Src251 was
not able to rescue and that the K295M kinase-dead Src
only partially rescued the phenotype. The best rescue was
obtained with SrcY416F (Schwartzberg et al., 1997), which
retains some kinase activity, albeit less than wild-type Src.
Interestingly, our model would predict that SrcY416F can-
not be downregulated by Cbl since it lacks the Cbl PTB
binding site. The fact that the kinase activity of this mutant
is low may have made further downregulation unnecessary
for a sufficient degree of cell motility. Hence, the most
likely interpretation is that some Src kinase activity is re-
quired for efficient assembly and/or disassembly of podo-
somes and, thereby, bone resorption.
Thus, we propose that the Src-dependent recruitment of
Cbl to adhesion sites acts to modulate the binding of the
vitronectin receptor. Failure to recruit either Src or Cbl, in
Src2 or Cbl2 osteoclasts, respectively, results in a decrease
in lamellipodia motility and cell migration. The observa-
tions reported here may therefore explain, at least in part,
the osteopetrotic phenotypes of Src-deleted (Soriano et
al., 1991) and Pyk2-deleted (Sims et al., 1999) mice.
It should be emphasized here that Pyk2 and Cbl recruit
other essential proteins to the Pyk2/Src/Cbl complex,
modulating cytoskeletal interactions and the turnover of
adhesion structures, although for the sake of simplification
we did not incorporate this information in our model. We
have shown that Cbl is able to homodimerize in a leucine
zipper-dependent manner (Bartkiewicz et al., 1999) so
that the recruitment of Cbl to sites of adhesion would cre-
ate a large number of potential binding sites for other pro-
teins such as PI3 kinase (Miyake et al., 1997). Similarly,
Pyk2 has been shown to be constitutively associated with
p130Cas in OCLs (Palecek et al., 1997). More intriguing is
our recent observation that the RING finger of Cbl re-
cruits the ubiquitin-conjugating enzyme UbCH7 (Yokou-The Journal of Cell Biology, Volume 152, 2001 194
chi et al., 1999) to EGF-induced molecular complexes,
leading to the ubiquitination and degradation of the acti-
vated EGFR complex. Thus, Cbl recruitment to the podo-
somes might also bring about ubiquitination, and subse-
quently degradation, of one or more adhesion-related
proteins. Indeed, activation-dependent ubiquitination of
Src has recently been reported in other systems. Further
experiments will be required to determine whether these
events also play a part in the regulation of adhesion struc-
tures and cell motility.
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